Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Repurposing an osteoporosis drug for β cell regeneration in diabetic patients.
Cell Metab. 22, 58-59 (2015)
Replenishing the lost or dysfunctional insulin-producing β cell mass in diabetic patients could slow down or reverse disease progression. Kondegowda et al. (2015) now show that osteoprotegerin and denosumab, inhibitors of the receptor activator of the NF-κB Ligand (RANKL) pathway and osteoclast activation, stimulate human β cell proliferation and therefore possess therapeutic potential.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
ISSN (print) / ISBN
1550-4131
e-ISSN
1932-7420
Zeitschrift
Cell Metabolism
Quellenangaben
Band: 22,
Heft: 1,
Seiten: 58-59
Verlag
Elsevier
Verlagsort
Cambridge
Begutachtungsstatus
Peer reviewed